Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Immunology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Atopic Dermatitis Clinical Trials

A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (208) clinical trials

If you have been diagnosed with moderate to severe eczema, also known as Atopic Dermatitis (AD), you may qualify to participate in a research study evaluating an investigational gel medication.   To qualify you must: • Be 12 years of age or older • Have relatively stable AD (i.e. your ...

Phase N/A

This voluntary study is testing an investigational medicine, called IDP-124, to see if it is safe to use on individuals 12 and older who have Moderate to Severe Atopic Dermatitis. WHAT WILL HAPPEN TO ME IN THIS STUDY? If you are able to be in the study, you, your parent(s) ...

Phase

This research study is being done to evaluate if the investigational drug, GBR 830, is safe and effective in subjects with moderate to severe atopic dermatitis.  This study is also looking at the biological activity of GBR 830 and how it is eliminated from the body.  GBR 830 is an ...

Phase

“I Just Can’t Stop Scratching.” If you’ve said this to yourself before, you might qualify for a clinical study for a new investigational oral medication for the itching associated with atopic dermatitis. Atopic dermatitis patients have difficulty with a variety of symptoms including itch and excessive scratching, lesions, scaring, infection, ...

Phase N/A

A randomised, double-blind, placebo-controlled trial to evaluate the effect of tralokinumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.  

Phase N/A

Local physicians are seeking adults with moderate to severe atopic dermatitis to participate in a clinical trial studying an experimental oral medication  

Phase

This is a double-blind, randomized, placebo-controlled, multicenter study to assess the efficacy, safety, and tolerability of Tralokinumab for the treatment of moderate to severe Atopic Dermatitis. All enrolled participants will receive subcutaneous injections of medication every two weeks for 52 weeks. There are 16 in-office visits throughout the study and ...

Phase

This is a multicenter double-blind, randomized, placebo-controlled study to assess the efficacy and safety of IDP-124 lotion for the treatment of moderate to severe atopic dermatitis (eczema). All enrolled subjects will receive a lotion medication to be applied twice daily for 6 weeks. There are 7 office visits throughout the ...

Phase

Unhappy with your options for eczema? Considering different options? Wake Research is enrolling volunteers in a study of the efficacy, safety and tolerability of an investigational ointment for mild to moderate eczema, also called atopic dermatitis. Your participation in the study could last up to three months. You’ll receive study-related ...

Phase N/A

There’s no hiding from atopic dermatitis. Why not check now to see if you may qualify for a clinical study? Right now, a clinical research study is testing an investigational topical cream on people with atopic dermatitis, a chronic, recurring, inflammatory, and itchy skin condition. If you (or your child) ...

Phase N/A